Impact of residual disease on overall survival in women with Federation of Gynecology and Obstetrics stage IIIB-IIIC vs stage IV epithelial ovarian cancer after primary surgery.

Sarah Mejer Sørensen Tine Henrichsen SchnackClaus Høgdall

Published in: Acta obstetricia et gynecologica Scandinavica (2018)

Our results confirm the positive prognostic impact of both complete cytoreduction and residual disease ≤1 cm in stages IIIB-IIIC as well as stage IV epithelial ovarian cancer. Women with stage IV do benefit from cytoreductive surgery and should be considered for primary debulking surgery, if residual disease = 0 can initially be expected.

Keyphrases

minimally invasive
coronary artery bypass
surgical site infection
neoadjuvant chemotherapy
radiation therapy
squamous cell carcinoma
coronary artery disease
acute coronary syndrome